1-4 of 4
Mary L. Ayres
Close
Sort by
Journal Articles

Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells

Amal A. El-Mabhouh, Mary L. Ayres, Elizabeth J. Shpall, Veerabhadran Baladandayuthapani, Michael J. Keating, William G. Wierda, Varsha Gandhi
Journal: Blood
Blood (2014) 123 (24): 3780–3789.
https://doi.org/10.1182/blood-2013-12-541433
Published: 2014
Includes: Supplemental data
Journal Articles

Phase I Study of Continuous-Infusion Nelarabine in Patients with Advanced Lymphoid Malignancies

Tapan Kadia, Varsha Gandhi, PhD, Deborah A. Thomas, MD, Farhad Ravandi, MD, William Plunkett, PhD, Mary L Ayres, Yuling Chen, Gracy Zacharian, Gautam Borthakur, Hagop M. Kantarjian, Michael J Keating, MD
Journal: Blood
Blood (2011) 118 (21): 4239.
https://doi.org/10.1182/blood.V118.21.4239.4239
Published: 2011
Journal Articles

8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma

Jennifer B. Dennison, Mala Shanmugam, Mary L. Ayres, Jun Qian, Nancy L. Krett, L. Jeffrey Medeiros, Sattva S. Neelapu, Steven T. Rosen, Varsha Gandhi
Journal: Blood
Blood (2010) 116 (25): 5622–5630.
https://doi.org/10.1182/blood-2010-05-285866
Published: 2010
Includes: Supplemental data
Journal Articles

Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells

Kumudha Balakrishnan, Jan A. Burger, Maite P. Quiroga, Marina Henneberg, Mary L. Ayres, William G. Wierda, Varsha Gandhi
Journal: Blood
Blood (2010) 116 (7): 1083–1091.
https://doi.org/10.1182/blood-2009-10-246199
Published: 2010
Includes: Supplemental data